KV Pharmaceutical Reaches Agreement with U.S. Department of Justice

ST. LOUIS, Feb. 25 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) ("the Company") today announced that it has reached an agreement, subject to court approval, with the United States Attorney for the Eastern District of Missouri and the Office of Consumer Litigation of the United

http://digg.com/u1OIcJ